Prostate cancer not likely to be cause of death in men with low-risk disease
the ONA take:
Relatively unaggressive prostate tumors are not likely to develop into metastatic disease or result in death, according to a study by researchers at the Brady Urological Institute at Johns Hopkins.
The researchers analyzed survival data of 1,298 men enrolled over the past 20 years in an active surveillance program Johns Hopkins. Of the participants, just two men died of prostate cancer, and three developed metastatic disease.
Urologists carefully selected which men were candidates for active surveillance and monitored the participants. Selection was based, in part, on Gleason scores determined by pathologic evaluation of prostate biopsy tissue.
In 1995, when the study began, the men underwent annual biopsy until age 75 years. Annual biopsies are no longer required among those men in the lowest risk group; however, when a biopsy is performed, MRI-guided technology is used and pathologists are asked to check biopsy tissue levels of proteins made by the PTEN gene, a biomarker for prostate cancer aggressiveness.
A benefit of using active surveillance for men who prostate cancer is very low or low-risk is reduction in rates of complications and costs of prostate cancer treatments.
Relatively unaggressive prostate tumors are not likely to develop into metastatic disease or result in death.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|